Broad immune engagement by afami-cel presented at AACR
The company presented additional translational data at AACR, showing that afami-cel induced peripheral and tumoral innate and adaptive immune responses in patients with SyS and MRCLS (link). Notably, following afami-cel infusion, a greater tumoral immune infiltrate was demonstrated at the gene and
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.